$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx

$amrx Overview Financials Valuation SEC Filings Company Website

2018 Q3 Form 10-Q Financial Statement

#000172312818000037 Filed on November 07, 2018

Income Statement

Concept	2018 Q3	2017 Q3
Revenue	$476.5M	$254.7M
YoY Change	87.05%	11.77%
Cost Of Revenue	$276.4M	$119.7M
YoY Change	130.86%	-69.56%
Gross Profit	$200.1M	$135.0M
YoY Change	48.21%	-181.63%
Gross Profit Margin	42.0%	53.0%
Selling, General & Admin	$75.49M	$27.44M
YoY Change	175.09%	-50.11%
% of Gross Profit	37.72%	20.32%
Research & Development	$42.35M	$41.32M
YoY Change	2.48%	105.59%
% of Gross Profit	21.16%	30.61%
Depreciation & Amortization	$17.36M	$10.68M
YoY Change	62.53%	-60.0%
% of Gross Profit	8.67%	7.91%
Operating Expenses	$117.8M	$68.76M
YoY Change	71.36%	-8.56%
Operating Profit	$74.56M	$78.75M
YoY Change	-5.33%	-132.73%
Interest Expense	-$43.02M	-$19.22M
YoY Change	123.84%	76.31%
% of Operating Profit	-57.7%	-24.4%
Other Income/Expense, Net	-$51.98M	-$52.37M
YoY Change	-0.74%	12992.25%
Pretax Income	$22.57M	$26.38M
YoY Change	-14.44%	-109.29%
Income Tax	$5.109M	-$738.0K
% Of Pretax Income	22.63%	-2.8%
Net Earnings	$6.888M	$0.00
YoY Change		-100.0%
Net Earnings / Revenue	1.45%	0.0%
Basic Earnings Per Share	$0.05	$0.00
Diluted Earnings Per Share	$0.05	$0.00
COMMON SHARES
Basic Shares Outstanding	127.2M
Diluted Shares Outstanding	128.2M

Balance Sheet

Concept	2018 Q3	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$165.2M	$157.7M
YoY Change	4.76%	-32.06%
Cash & Equivalents	$165.2M	$19.35M
Short-Term Investments
Other Short-Term Assets	$40.20M	$60.70M
YoY Change	-33.77%	-0.98%
Inventory	$490.8M	$172.8M
Prepaid Expenses
Receivables	$641.0M	$242.0M
Other Receivables	$18.36M	$0.00
Total Short-Term Assets	$1.431B	$633.2M
YoY Change	126.04%	-9.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$567.5M	$223.2M
YoY Change	154.26%	-1.93%
Goodwill	$410.6M
YoY Change
Intangibles	$1.733B
YoY Change
Long-Term Investments
YoY Change
Other Assets	$73.64M	$75.40M
YoY Change	-2.33%	-17.95%
Total Long-Term Assets	$3.151B	$1.016B
YoY Change	210.11%	-28.41%
TOTAL ASSETS
Total Short-Term Assets	$1.431B	$633.2M
Total Long-Term Assets	$3.151B	$1.016B
Total Assets	$4.582B	$1.649B
YoY Change	177.83%	-22.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$124.5M	$53.70M
YoY Change	131.92%	-13.25%
Accrued Expenses	$388.6M	$249.3M
YoY Change	55.88%	-2.2%
Deferred Revenue
YoY Change
Short-Term Debt	$78.10M	$0.00
YoY Change
Long-Term Debt Due	$121.7M	$17.80M
YoY Change	583.71%	0.56%
Total Short-Term Liabilities	$749.3M	$349.0M
YoY Change	114.69%	4.33%
LONG-TERM LIABILITIES
Long-Term Debt	$2.675B	$767.9M
YoY Change	248.37%	-5.48%
Other Long-Term Liabilities	$44.77M	$48.30M
YoY Change	-7.31%	-29.9%
Total Long-Term Liabilities	$2.917B	$816.2M
YoY Change	257.44%	-7.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$749.3M	$349.0M
Total Long-Term Liabilities	$2.917B	$816.2M
Total Liabilities	$3.667B	$1.167B
YoY Change	214.15%	-4.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.15M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$501.1M	$481.9M
YoY Change
Total Liabilities & Shareholders Equity	$4.582B	$1.649B
YoY Change	177.83%	-22.2%

Cashflow Statement

Concept	2018 Q3	2017 Q3
OPERATING ACTIVITIES
Net Income	$6.888M	$0.00
YoY Change		-100.0%
Depreciation, Depletion And Amortization	$17.36M	$10.68M
YoY Change	62.53%	-60.0%
Cash From Operating Activities	$62.20M	-$11.40M
YoY Change	-645.61%	-114.2%
INVESTING ACTIVITIES
Capital Expenditures	-$37.50M	-$5.200M
YoY Change	621.15%	-54.39%
Acquisitions
YoY Change
Other Investing Activities	-$3.300M	$8.800M
YoY Change	-137.5%	-101.5%
Cash From Investing Activities	-$40.80M	$3.600M
YoY Change	-1233.33%	-100.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	82.60M	-5.500M
YoY Change	-1601.82%	-101.44%
NET CHANGE
Cash From Operating Activities	62.20M	-11.40M
Cash From Investing Activities	-40.80M	3.600M
Cash From Financing Activities	82.60M	-5.500M
Net Change In Cash	104.0M	-13.30M
YoY Change	-881.95%	-90.15%
FREE CASH FLOW
Cash From Operating Activities	$62.20M	-$11.40M
Capital Expenditures	-$37.50M	-$5.200M
Free Cash Flow	$99.70M	-$6.200M
YoY Change	-1708.06%	-106.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	15043000	USD
CY2017Q4	amrx	Accrued Sales Rebates Current AccruedSalesRebatesCurrent	12911000	USD
CY2018Q3	amrx	Accrued Sales Rebates Current AccruedSalesRebatesCurrent	88942000	USD
CY2017Q4	amrx	Accrued Sales Returns Allowance Current AccruedSalesReturnsAllowanceCurrent	45175000	USD
CY2018Q3	amrx	Accrued Sales Returns Allowance Current AccruedSalesReturnsAllowanceCurrent	139698000	USD
CY2017Q4	amrx	Allowance For Accounts Receivable Current AllowanceForAccountsReceivableCurrent	475935000	USD
CY2018Q3	amrx	Allowance For Accounts Receivable Current AllowanceForAccountsReceivableCurrent	657838000	USD
CY2017Q3	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-3374000	USD
	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-145065000	USD
CY2018Q3	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	6952000	USD
	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-21502000	USD
CY2017Q3	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	2271000	USD
	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	2353000	USD
CY2018Q3	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	2231000	USD
	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	216873000	USD
CY2018Q3	amrx	Capital Leases Future Minimum Payments Due In Six Years CapitalLeasesFutureMinimumPaymentsDueInSixYears	5200000	USD
CY2017Q4	amrx	Cash Discount Allowances Current CashDiscountAllowancesCurrent	20408000	USD
CY2018Q3	amrx	Cash Discount Allowances Current CashDiscountAllowancesCurrent	29676000	USD
CY2017Q4	amrx	Contract Charge Backs And Sales Volume Allowances Current ContractChargeBacksAndSalesVolumeAllowancesCurrent	453703000	USD
CY2018Q3	amrx	Contract Charge Backs And Sales Volume Allowances Current ContractChargeBacksAndSalesVolumeAllowancesCurrent	625518000	USD
CY2018Q2	amrx	Deferred Tax Asset Basis Difference In Investment Portion Attributable To Acquirer Prior To Business Combination DeferredTaxAssetBasisDifferenceInInvestmentPortionAttributableToAcquirerPriorToBusinessCombination	305400000	USD
CY2018Q2	amrx	Deferred Tax Asset Operating Loss Carryforward Portion Attributable To Acquirer Prior To Business Combination DeferredTaxAssetOperatingLossCarryforwardPortionAttributableToAcquirerPriorToBusinessCombination	52000000	USD
	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	33094000	USD
	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	89910000	USD
CY2018Q3	amrx	Dueto Related Parties Tax Distribution DuetoRelatedPartiesTaxDistribution	35500000	USD
CY2018Q3	amrx	Finite Lived Intangible Assets Amortization Expense After Year Six FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix	488326000	USD
CY2018Q3	amrx	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	124238000	USD
CY2017Q4	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	0	USD
CY2018Q3	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	195820000	USD
CY2018Q3	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	195800000	USD
CY2017Q4	amrx	Longterm Debtand Capital Lease Obligations Including Debt Issuance Costs LongtermDebtandCapitalLeaseObligationsIncludingDebtIssuanceCosts	1493458000	USD
CY2018Q3	amrx	Longterm Debtand Capital Lease Obligations Including Debt Issuance Costs LongtermDebtandCapitalLeaseObligationsIncludingDebtIssuanceCosts	2832661000	USD
CY2017Q3	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	26780000	USD
	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	106079000	USD
CY2018Q3	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	0	USD
	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	-148806000	USD
	amrx	Number Of Product Families NumberOfProductFamilies	200	product
CY2018Q3	amrx	Operating Leases Future Minimum Payments Duein Six Years OperatingLeasesFutureMinimumPaymentsDueinSixYears	10043000	USD
CY2017Q3	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	6725000	USD
	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	-4219000	USD
CY2018Q3	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	0	USD
	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	1721000	USD
CY2017Q4	amrx	Prepaid Regulatory Fees Current PrepaidRegulatoryFeesCurrent	5926000	USD
CY2018Q3	amrx	Prepaid Regulatory Fees Current PrepaidRegulatoryFeesCurrent	701000	USD
	amrx	Profit Share And Transaction Related Bonus Expense ProfitShareAndTransactionRelatedBonusExpense	186500000	USD
CY2017Q3	amrx	Profit Sharing Expense ProfitSharingExpense	0	USD
	amrx	Profit Sharing Expense ProfitSharingExpense	0	USD
CY2018Q3	amrx	Profit Sharing Expense ProfitSharingExpense	0	USD
CY2018Q3	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	0	USD
	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	27742000	USD
	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	27700000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-09-30
	amrx	Profit Sharing Expense ProfitSharingExpense	158800000	USD
	amrx	Profit Sharing Expense ProfitSharingExpense	158757000	USD
	amrx	Redeemable Noncontrolling Interest Decrease From Repurchase Of Temporary Equity RedeemableNoncontrollingInterestDecreaseFromRepurchaseOfTemporaryEquity	-11775000	USD
	amrx	Restructuring And Related Cost Expected Cost Period RestructuringAndRelatedCostExpectedCostPeriod	P15M
CY2017Q4	amrx	Sales Rebate Reimbursement Current SalesRebateReimbursementCurrent	15000000	USD
CY2018Q3	amrx	Sales Rebate Reimbursement Current SalesRebateReimbursementCurrent	15000000	USD
	amrx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConverted	3000000	shares
	amrx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConverted	3002669	shares
	amrx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConvertedWeightedAverageExercisePrice	18.90
CY2018Q2	amrx	Shares Repurchased Percentage SharesRepurchasedPercentage	0.15
	amrx	Tax Distribution To Noncontrolling Interest TaxDistributionToNoncontrollingInterest	0	USD
	amrx	Tax Distribution To Noncontrolling Interest TaxDistributionToNoncontrollingInterest	35543000	USD
	amrx	Transaction Costs Paid By Parent TransactionCostsPaidByParent	2008000	USD
	amrx	Transaction Costs Paid By Parent TransactionCostsPaidByParent	0	USD
CY2017Q3	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	0	USD
	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	0	USD
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001723128
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Amneal Pharmaceuticals, Inc.
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Trading Symbol TradingSymbol	AMRX
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	194779000	USD
CY2018Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	513122000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	70013000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	124539000	USD
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	827302000	USD
CY2018Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1298867000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	351367000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	641029000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	938000	USD
CY2018Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8652000	USD
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2970000	USD
CY2018Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	19625000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	156370000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	193069000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14232000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9889000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8562000	USD
CY2018Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	520160000	USD
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	11708000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5234000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3590000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5234000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1824000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2644000	USD
CY2017Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1400000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3895000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3900000	USD
CY2018Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1600000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4200000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4220000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1278000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3051000	USD
CY2018Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25655000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	44109000	USD
CY2017Q4	us-gaap	Assets Assets	1341889000	USD
CY2018Q3	us-gaap	Assets Assets	4582048000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	771933000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	1431301000	USD
CY2017Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-29975000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-370286000	USD
CY2018Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	17465000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-143585000	USD
CY2017Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	461125000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1333162000	USD
CY2018Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	476487000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1341555000	USD
CY2017Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2271000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2353000	USD
CY2018Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2231000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	30374000	USD
CY2017Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	40298000	USD
CY2018Q3	us-gaap	Capital Lease Obligations CapitalLeaseObligations	39411000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	300000	USD
CY2018Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	300000	USD
CY2018Q3	us-gaap	Capital Leased Assets Number Of Units CapitalLeasedAssetsNumberOfUnits	2	building
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	129100000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5200000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5200000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5200000	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5200000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77922000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	172193000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16192000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	94271000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1851000	USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	101800000	USD
CY2017Q4	us-gaap	Common Unit Authorized CommonUnitAuthorized	189000000	shares
CY2018Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1617000	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21354000	USD
CY2018Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1300000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19348000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74166000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165192000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37546000	USD
CY2017Q4	us-gaap	Common Unit Issued CommonUnitIssued	189000000	shares
CY2017Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	189000000	shares
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	0	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	0	USD
CY2018Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3568000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16706000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	119720000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	365523000	USD
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	276382000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	642468000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	4977000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8715000	USD
CY2018Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	35859000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	898000	USD
CY2018Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	365971000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-534000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9111000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2491000	USD
CY2018Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1761000	USD
CY2017Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1900000	USD
CY2018Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2300000	USD
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	6600000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	10680000	USD
	us-gaap	Depreciation Depreciation	30043000	USD
CY2018Q3	us-gaap	Depreciation Depreciation	17358000	USD
	us-gaap	Depreciation Depreciation	45801000	USD
	us-gaap	Distribution Made To Limited Partner Cash Distributions Declared DistributionMadeToLimitedPartnerCashDistributionsDeclared	191560000	USD
CY2017Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2018Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8562000	USD
CY2017Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	16210000	USD
CY2018Q3	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	925000	USD
CY2017Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	12622000	USD
CY2018Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	36329000	USD
CY2018Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1204000	USD
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.028
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.019
CY2018Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.226
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.037
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23954000	USD
CY2018Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	72624000	USD
CY2018Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	44500000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y6M12D
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19447000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	63235000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	25959000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	145339000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	141879000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	126061000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	115347000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	62896000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1230384000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43449000	USD
CY2018Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1167149000	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-4178000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	25751000	USD
CY2018Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-5137000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-22518000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	27692000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-21560000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-28880000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-28880000	USD
CY2018Q3	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-2812000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-2812000	USD
CY2017Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	21467000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	21467000	USD
CY2018Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2531000	USD
CY2018Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19667000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19700000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	28441000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	26444000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	410616000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	386405000	USD
CY2017	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1898000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-2233000	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3895000	USD
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	135013000	USD
	us-gaap	Gross Profit GrossProfit	374762000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	200105000	USD
	us-gaap	Gross Profit GrossProfit	522995000	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	8474000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26384000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	109248000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22574000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-187916000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-738000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2117000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5109000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6943000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4017000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5379000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2018Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	74782000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5583000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-26858000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-48468000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	74711000	USD
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-1397000	USD
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-10828000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	6010000	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-14125000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25186000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	53708000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	18604000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9803000	USD
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1150000	USD
CY2018Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	565871000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	64046000	USD
CY2018Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1796255000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44599000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1733020000	USD
CY2017Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1100000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	4100000	USD
CY2018Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	500000	USD
CY2017Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-19218000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	490768000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	140051000	USD
CY2018Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	205144000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	1510000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	38146000	USD
CY2018Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	51068000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1341889000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4582048000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	296883000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	749271000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-51105000	USD
CY2018Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-43018000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-100691000	USD
	us-gaap	Interest Paid Net InterestPaidNet	47968000	USD
	us-gaap	Interest Paid Net InterestPaidNet	89075000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	105841000	USD
CY2018Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	234556000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	284038000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	20755000	USD
CY2017Q3	us-gaap	Legal Fees LegalFees	6693000	USD
	us-gaap	Legal Fees LegalFees	17786000	USD
CY2018Q3	us-gaap	Legal Fees LegalFees	4401000	USD
	us-gaap	Legal Fees LegalFees	13024000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1420588000	USD
CY2018Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2917458000	USD
CY2017Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-375582000	USD
CY2017Q4	us-gaap	Litigation Reserve LitigationReserve	15000000	USD
CY2018Q3	us-gaap	Litigation Reserve LitigationReserve	15000000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	1395261000	USD
CY2018Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2675108000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	89482000	USD
CY2018Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	121694000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	1484743000	USD
CY2018Q3	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2796802000	USD
CY2017Q4	us-gaap	Members Capital MembersCapital	2716000	USD
CY2017Q4	us-gaap	Members Equity MembersEquity	-385739000	USD
CY2017Q4	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	10157000	USD
CY2018Q3	us-gaap	Minority Interest MinorityInterest	414214000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	35543000	USD
CY2018Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	35500000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	35500000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-95511000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	506595000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-89653000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9421000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-401699000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	168922000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-32331000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	6888000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-10976000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	342000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1052000	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10577000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-21191000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6952000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12152000	USD
	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	18283000	USD
	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2518000	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	360000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-52369000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-56836000	USD
CY2018Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-51981000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-144963000	USD
CY2017Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0	USD
CY2018Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	78126000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	78753000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	166084000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	74555000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-42953000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	103612000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	10329000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	11105000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	12071000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	25885000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	28128000	USD
CY2018Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	6051000	USD
CY2017Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4400000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	13000000	USD
CY2018Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5600000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	12900000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23818000	USD
CY2018Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30505000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11257000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	73642000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1721000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10685000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6725000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4219000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-7939000	USD
CY2018Q2	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	11800000	USD
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	11775000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8964000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	0	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-4555000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-6131000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3384000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4554000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7793000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	44769000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-431000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1955000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-93000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-71000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1014000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	725000	USD
CY2017Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	16315000	USD
CY2018Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	23854000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15150000	USD
CY2018Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	18363000	USD
	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	27742000	USD
	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	158757000	USD
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	355265000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	182998000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	183000000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5026000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	54955000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	324634000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19500000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	70153000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	63065000	USD
CY2018Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2018Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42396000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	126386000	USD
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3154000	USD
CY2018Q3	us-gaap	Prepaid Insurance PrepaidInsurance	7069000	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	40000	USD
	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	27742000	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	250000000	USD
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1325383000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	25000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	25000000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	360000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3162000	USD
	us-gaap	Profit Loss ProfitLoss	-148709000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	27122000	USD
	us-gaap	Profit Loss ProfitLoss	107131000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	17465000	USD
	us-gaap	Profit Loss ProfitLoss	-180973000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	643128000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	760567000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	486758000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	567498000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2018Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	10260000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	610482000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	14842000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41323000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	127926000	USD
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42999000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	137543000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2006000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3756000	USD
CY2018Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	7001000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2018Q3	us-gaap	Restructuring Charges RestructuringCharges	-2200000	USD
CY2018Q3	us-gaap	Restructuring Charges RestructuringCharges	-2156000	USD
	us-gaap	Restructuring Charges RestructuringCharges	42309000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-382785000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12152000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254733000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	740285000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476487000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1165463000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	27440000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	82080000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	78075000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	156199000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3162000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	278302	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1483143000	USD
CY2018Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-64000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	163991000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y6M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2521662	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	19.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2600000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	325048	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3462780	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5862099	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.00
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.61
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	11.36
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.86
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.58
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	15300	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M12D
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	501105000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	915319000	USD
	us-gaap	Stockholders Equity Other StockholdersEquityOther	3714000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	11708000	USD
CY2017Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1176000	USD
	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	67000	USD
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	128222000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127196000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127247000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127196000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, bill backs, allowances for accounts receivable, accrued liabilities, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001723128-18-000037-index-headers.html	Edgar Link	pending
0001723128-18-000037-index.html	Edgar Link	pending
0001723128-18-000037.txt	Edgar Link	pending
0001723128-18-000037-xbrl.zip	Edgar Link	pending
amrx-09x30x201810qdoc.htm	Edgar Link	pending
amrx-09x30x2018x10qxex311s.htm	Edgar Link	pending
amrx-09x30x2018x10qxex312r.htm	Edgar Link	pending
amrx-09x30x2018x10qxex321s.htm	Edgar Link	pending
amrx-09x30x2018x10qxex322x.htm	Edgar Link	pending
amrx-20180930.xml	Edgar Link	completed
amrx-20180930.xsd	Edgar Link	pending
amrx-20180930_cal.xml	Edgar Link	unprocessable
amrx-20180930_def.xml	Edgar Link	unprocessable
amrx-20180930_lab.xml	Edgar Link	unprocessable
amrx-20180930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx

2018 Q3 Form 10-Q Financial Statement

#000172312818000037 Filed on November 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRX Amneal Pharmaceuticals, Inc. Stock $amrx

2018 Q3 Form 10-Q Financial Statement

#000172312818000037 Filed on November 07, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx